2013
DOI: 10.1016/j.ejmech.2013.02.019
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, biological activity and resistance to proteolytic digestion of new cyclic dermorphin/deltorphin analogues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…It is worth mentioning that u KTP‐NH 2 also had a more enduring analgesic effect than KTP‐NH 2 . Therefore, the substitution of a peptide bond by a urea bond probably succeeded in conferring resistance to peptidases relative to KTP‐NH 2 without complete loss of analgesic power.…”
Section: Discussionmentioning
confidence: 99%
“…It is worth mentioning that u KTP‐NH 2 also had a more enduring analgesic effect than KTP‐NH 2 . Therefore, the substitution of a peptide bond by a urea bond probably succeeded in conferring resistance to peptidases relative to KTP‐NH 2 without complete loss of analgesic power.…”
Section: Discussionmentioning
confidence: 99%
“…One of the analogues, namely the N ε ,N β ‐carbonyl‐D‐Lys 2 ,Dap 5 ]enkephalinamide (or {[Tyr‐D‐Lys(& 1 )‐Gly‐Phe‐Dap(& 2 )‐NH 2 ][& 1 CO& 2 ]} according to the abbreviated nomenclature, ) is an analogue which also showed a strong and long‐lasting antinociception effect in both hot‐plate and tail‐immersion tests for rats after central administration . Recently, while continuing this study, we reported a novel series of tetrapeptide N ‐ureidoethylamides based on the deltorphin(1–4) structure . The antinociceptive activities of these analogues were evaluated using hot‐plate and tail‐flick tests after intravenous application.…”
Section: Introductionmentioning
confidence: 73%
“…The most active analogue {[Tyr‐D‐Lys(& 1 )‐Phe‐Dab(& 2 )‐CH 2 CH 2 NH‐CONH 2 ] [& 1 CO& 2 ]} 1 showed a significant antinociceptive effect after systemic application, stronger than morphine. Moreover, all peptides described in this study were completely resistant toward proteolytic enzymes, likely due to the presence of D‐amino acid residue in position 2 of the peptide chain and the rigid cyclic structure with carbonyl bridge.…”
Section: Introductionmentioning
confidence: 91%
“…Because pain relief is mediated mainly through MOR, it is important to understand the interactions between MOR ligands and the receptor. Therefore, hundreds of analogues of the dermorphin and dermorphin‐like peptides have been synthesised .…”
Section: Introductionmentioning
confidence: 99%